Pathalys Pharma Email Format
Biotechnology ResearchNorth Carolina, United States11-50 Employees
Pathalys Pharma is a private biotechnology company concentrating on end-stage renal disease and late-stage CKD, developing advanced therapeutics to address unmet clinical needs. It aims to build a multi-asset portfolio of ESRD treatments through its collaboration with Catalys Pacific and DaVita. The company operates in the biotechnology research sector, focusing on therapies to improve kidney-disease management for patients. It is based in Raleigh, North Carolina. In August 2024, Pathalys appointed Dr. Bastian Dehmel as Chief Medical Officer.